Global Organ-on-a-Chip Market Growth (Status and Outlook) 2024-2030

Global Organ-on-a-Chip Market Growth (Status and Outlook) 2024-2030

According to our LPI (LP Information) latest study, the global Organ-on-a-Chip market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Organ-on-a-Chip is forecast to a readjusted size of US$ 613.2 million by 2030 with a CAGR of 32.4% during review period.

The research report highlights the growth potential of the global Organ-on-a-Chip market. Organ-on-a-Chip are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Organ-on-a-Chip. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Organ-on-a-Chip market.

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).

In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

Global organ on chip key players include Emulate, TissUse, Mimetas, CN Bio Innovations, Valo Health, etc. Global top 5 manufacturers hold a share about 58%.

North America is the largest market, with a share about 42%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Liver-on-a-chip is the largest segment, with a share about 26%. And in terms of application, the largest application is pharmaceutical & biotechnology companies, followed by academic & research institutes.

Key Features:

The report on Organ-on-a-Chip market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Organ-on-a-Chip market. It may include historical data, market segmentation by Type (e.g., Brain-on-a-chip, Liver-on-a-chip), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Organ-on-a-Chip market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Organ-on-a-Chip market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Organ-on-a-Chip industry. This include advancements in Organ-on-a-Chip technology, Organ-on-a-Chip new entrants, Organ-on-a-Chip new investment, and other innovations that are shaping the future of Organ-on-a-Chip.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Organ-on-a-Chip market. It includes factors influencing customer ' purchasing decisions, preferences for Organ-on-a-Chip product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Organ-on-a-Chip market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Organ-on-a-Chip market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Organ-on-a-Chip market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Organ-on-a-Chip industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Organ-on-a-Chip market.

Market Segmentation:

Organ-on-a-Chip market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.

Segmentation by type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs

Segmentation by end user
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo, Inc.
Beijing Daxiang Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.